Scientists examine immune clues in ovarian cancer
NCT ID NCT07528911
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This completed study looked at tumor samples from 687 women with advanced high-grade serous ovarian cancer who were treated with chemotherapy. Researchers examined different types of immune cells in the tumors to see if they were linked to how well patients did. The goal was to better understand the role of the immune system in this type of cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better predict how patients with ovarian cancer will respond to standard chemotherapy.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks at existing tissue samples, so it cannot prove cause and effect or lead directly to a new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL HIGH GRADE SEROUS OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hellenic Cooperative Oncology Group
Athens, Greece